New clinical study shows Nevisense potential for assessment of Skin Barrier and Atopic Dermatitis
In the study Nevisense was used to assess the skin barrier of patients with atopic dermatitis (AD) and could accurately detect signs of atopic dermatitis even on unaffected skin.
- In the study Nevisense was used to assess the skin barrier of patients with atopic dermatitis (AD) and could accurately detect signs of atopic dermatitis even on unaffected skin.
- The Nevisense measurement also correlated with relevant biomarkers for atopic dermatitis.\nSIAF, based in Davos, is a world leader within applied allergy and asthma research.
- Skin barrier assessment shows potential to be clinically useful for early prediction of disease development, improved diagnosis, disease follow-up and therapy evaluation.\nThis study shows that the Nevisense method can directly assess the status of epithelial barrier using electrical impedance spectroscopy (EIS).
- Furthermore, copy numbers of filaggrin, an essential skin barrier molecule significantly correlated with EIS on non-lesional skin of patients.